D.R. Horton (NYSE:DHI) Given Underperform Rating at Wedbush

Wedbush restated their underperform rating on shares of D.R. Horton (NYSE:DHI – Free Report) in a research report sent to investors on Thursday, Benzinga reports. They currently have a $130.00 price objective on the construction company’s stock. A number of other equities research analysts have also recently commented on the company. Citigroup raised their price […]

Related Keywords

Canada ,United States ,Barbarak Allen ,Davidv Auld , ,Goldman Sachs Group ,Rise Advisors ,Barclays ,Royal Bank ,Citigroup ,Dr Horton Company Profile ,Fairfield Bush ,Riverview Trust Co ,Dr Horton Inc ,Mascoma Wealth Management ,Free Report ,Moderate Buy ,Get Free Report ,Director Barbara ,Street Markets ,Wealth Management ,South Central ,Dr Horton ,Nyse Dhi ,Dhi ,Construction ,23331a10 ,Reiterated Rating ,Wedbush ,